Company
Headquarters: Singapore, Singapore
Employees: 51
HK$137.2 Million
HKD as of Jan. 1, 2024
US$17.6 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
RMH Holdings Limited, an investment holding company, provides dermatology treatment solutions in Singapore, Hong Kong, and internationally. The company operates in two segments, Healthcare service and Trading sales. It offers specialty care services for various dermatological conditions affecting skin, hair, and nails through medical, surgical, laser, and aesthetic treatments. The company also engages in treating skin cancer and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; and providing consultancy, prescription, and dispensing services. It operates three clinics at Orchard Road, Raffles Place, and East Coast. The company was incorporated in 2017 and is headquartered in Singapore. RMH Holdings Limited is a subsidiary of Brisk Success Holdings Limited.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
RMH Holdings Ltd has the following listings and related stock indices.
Stock: HKEX: 8437 wb_incandescent